Smithbridge Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.37M | Sell |
61,975
-61,891
| -50% | -$5.93M | 0.8% | 40 |
|
|
2025
Q4 | $11.9M | Buy |
123,866
+61,991
| +100% | +$6.02M | 1.02% | 36 |
|
|
2025
Q3 | $5.89M | Sell |
61,875
-543
| -0.9% | -$49.9K | 0.86% | 44 |
|
|
2025
Q2 | $5.44M | Buy |
62,418
+2,140
| +4% | +$181K | 0.95% | 44 |
|
|
2025
Q1 | $5.42M | Buy |
+60,278
| New | +$5.39M | 1% | 37 |
|
|
2024
Q3 | $5.34M | Buy |
59,327
+3,757
| +7% | +$316K | 0.92% | 39 |
|
|
2024
Q2 | $4.37M | Sell |
55,570
-110
| -0.2% | -$9.02K | 0.91% | 36 |
|
|
2024
Q1 | $4.85M | Buy |
55,680
+6,938
| +14% | +$592K | 1% | 38 |
|
|
2023
Q4 | $4.01M | Sell |
48,742
-1,141
| -2% | -$87K | 0.91% | 42 |
|
|
2023
Q3 | $3.91M | Buy |
49,883
+1,528
| +3% | +$128K | 0.97% | 39 |
|
|
2023
Q2 | $4.26M | Buy |
48,355
+1,112
| +2% | +$95.7K | 1% | 39 |
|
|
2023
Q1 | $3.81M | Buy |
47,243
+4,255
| +10% | +$347K | 0.96% | 37 |
|
|
2022
Q4 | $3.34M | Sell |
42,988
-7,802
| -15% | -$632K | 0.89% | 44 |
|
|
2022
Q3 | $4.1M | Buy |
50,790
+1,879
| +4% | +$169K | 1.68% | 24 |
|
|
2022
Q2 | $4.39M | Buy |
48,911
+164
| +0.3% | +$16.6K | 1.7% | 23 |
|
|
2022
Q1 | $5.41M | Buy |
48,747
+2,632
| +6% | +$278K | 1.79% | 20 |
|
|
2021
Q4 | $4.77M | Buy |
46,115
+1,337
| +3% | +$155K | 1.45% | 31 |
|
|
2021
Q3 | $5.61M | Sell |
44,778
-939
| -2% | -$122K | 1.86% | 17 |
|
|
2021
Q2 | $5.67M | Buy |
45,717
+730
| +2% | +$91.7K | 1.85% | 18 |
|
|
2021
Q1 | $5.31M | Buy |
44,987
+4,090
| +10% | +$479K | 2.27% | 15 |
|
|
2020
Q4 | $4.79M | Buy |
40,897
+1,705
| +4% | +$188K | 2.21% | 15 |
|
|
2020
Q3 | $4.07M | Buy |
39,192
+800
| +2% | +$80.3K | 2.1% | 18 |
|
|
2020
Q2 | $3.52M | Buy |
38,392
+4,615
| +14% | +$443K | 1.96% | 20 |
|
|
2020
Q1 | $3.05M | Buy |
33,777
+1,065
| +3% | +$113K | 2.04% | 22 |
|
|
2019
Q4 | $3.71M | Buy |
32,712
+48
| +0.1% | +$5.27K | 1.91% | 23 |
|
|
2019
Q3 | $3.55M | Buy |
32,664
+360
| +1% | +$37.6K | 2% | 22 |
|
|
2019
Q2 | $3.15M | Buy |
32,304
+300
| +0.9% | +$27.4K | 1.82% | 23 |
|
|
2019
Q1 | $2.92M | Buy |
32,004
+850
| +3% | +$76.1K | 1.75% | 27 |
|
|
2018
Q4 | $2.83M | Buy |
31,154
+514
| +2% | +$48K | 1.99% | 22 |
|
|
2018
Q3 | $3.01M | Sell |
30,640
-237
| -0.8% | -$21.9K | 1.81% | 25 |
|
|
2018
Q2 | $2.64M | Buy |
30,877
+1,890
| +7% | +$158K | 1.69% | 27 |
|
|
2018
Q1 | $2.33M | Buy |
28,987
+745
| +3% | +$61.5K | 1.54% | 31 |
|
|
2017
Q4 | $2.28M | Buy |
28,242
+2,274
| +9% | +$182K | 1.44% | 32 |
|
|
2017
Q3 | $2.02M | Sell |
25,968
-668
| -3% | -$55.5K | 1.42% | 32 |
|
|
2017
Q2 | $2.36M | Sell |
26,636
-245
| -0.9% | -$20.7K | 1.95% | 20 |
|
|
2017
Q1 | $2.17M | Sell |
26,881
-14,995
| -36% | -$1.17M | 1.9% | 23 |
|
|
2016
Q4 | $2.98M | Sell |
41,876
-4,506
| -10% | -$354K | 2.64% | 12 |
|
|
2016
Q3 | $4.01M | Sell |
46,382
-5,600
| -11% | -$488K | 3.59% | 5 |
|
|
2016
Q2 | $4.51M | Sell |
51,982
-400
| -0.8% | -$32.3K | 4.19% | 3 |
|
|
2016
Q1 | $3.93M | Sell |
52,382
-2,800
| -5% | -$211K | 3.66% | 5 |
|
|
2015
Q4 | $4.25M | Sell |
55,182
-1,000
| -2% | -$75.3K | 3.91% | 6 |
|
|
2015
Q3 | $3.76M | Sell |
56,182
-1,200
| -2% | -$88.4K | 3.56% | 6 |
|
|
2015
Q2 | $4.25M | Sell |
57,382
-2,700
| -4% | -$206K | 3.57% | 5 |
|
|
2015
Q1 | $4.69M | Sell |
60,082
-700
| -1% | -$53.1K | 3.87% | 2 |
|
|
2014
Q4 | $4.39M | Sell |
60,782
-142
| -0.2% | -$9.86K | 3.59% | 5 |
|
|
2014
Q3 | $3.77M | Sell |
60,924
-1,201
| -2% | -$76.4K | 3.16% | 7 |
|
|
2014
Q2 | $3.96M | Buy |
62,125
+25
| +0% | +$1.52K | 3.34% | 7 |
|
|
2014
Q1 | $3.82M | Sell |
62,100
-4,975
| -7% | -$290K | 3.47% | 4 |
|
|
2013
Q4 | $3.85M | Sell |
67,075
-1,932
| -3% | -$110K | 3.53% | 4 |
|
|
2013
Q3 | $3.67M | Buy |
69,007
+100
| +0.1% | +$5.38K | 3.48% | 4 |
|
|
2013
Q2 | $3.55M | Buy |
+68,907
| New | +$3.41M | 3.59% | 3 |
|
Other funds holding MDT
VCM
VPM
Smithbridge Asset Management's MDT Position: Q1 2026 in Review
Smithbridge Asset Management reduced its Medtronic (MDT) stake by 50% in Q1 2026, selling an estimated $5.93M and leaving 61,975 shares worth $5.37M. The position accounts for 0.8% of the portfolio, ranked #40.
Smithbridge Asset Management first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $11.9M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Smithbridge Asset Management held 61,975 shares of Medtronic worth $5.37M as of Q1 2026.
- Smithbridge Asset Management sold 61,891 Medtronic shares in Q1 2026, an estimated $5.93M.
- Medtronic made up 0.8% of Smithbridge Asset Management's portfolio in Q1 2026, its #40 holding.
- Smithbridge Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
- Smithbridge Asset Management's Medtronic position peaked at $11.9M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Smithbridge Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.